Tirdzniecība OrthoPediatrics Corp. - KIDS CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Starpība | 0.10 | ||||||||
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.024874% | ||||||||
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | 0.002651% | ||||||||
Nakts laika nodeva | 21:00 (UTC) | ||||||||
Min. tirgotais daudzums | 1 | ||||||||
Valūta | USD | ||||||||
Drošības rezerve | 20% | ||||||||
Fondu birža | United States of America | ||||||||
Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Iepriekš. aizvērt* | 43.67 |
Atvērt* | 43.47 |
Izmaiņas par 1 gadu* | -19.8% |
Dienas Diapazons* | 43.47 - 44.88 |
52 ned Diapazons | 35.67-60.75 |
Vidējais apjoms (10 dienas) | 99.92K |
Vidējais apjoms (3 mēneši) | 2.61M |
Tirgus Kapitalizācija | 982.28M |
Cenas/Peļņas Attiecība | 8,772.07 |
Izvietotās Akcijas | 22.99M |
Ieņēmumi | 122.29M |
EPS | 0.00 |
Dividende (Ienesīgums %) | N/A |
Beta | 0.89 |
Nākamās Peļņas Datums | May 2, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
---|---|---|---|---|---|---|
Mar 31, 2023 | 44.22 | 1.50 | 3.51% | 42.72 | 44.91 | 42.25 |
Mar 30, 2023 | 43.67 | 1.17 | 2.75% | 42.50 | 44.31 | 42.42 |
Mar 29, 2023 | 42.59 | 0.75 | 1.79% | 41.84 | 42.90 | 41.84 |
Mar 28, 2023 | 42.62 | 1.16 | 2.80% | 41.46 | 42.65 | 40.62 |
Mar 27, 2023 | 41.77 | 1.80 | 4.50% | 39.97 | 42.14 | 39.97 |
Mar 24, 2023 | 41.72 | 1.34 | 3.32% | 40.38 | 42.01 | 40.00 |
Mar 23, 2023 | 41.29 | 1.60 | 4.03% | 39.69 | 42.34 | 39.69 |
Mar 22, 2023 | 41.04 | -1.00 | -2.38% | 42.04 | 42.98 | 41.00 |
Mar 21, 2023 | 42.95 | 0.74 | 1.75% | 42.21 | 43.20 | 42.18 |
Mar 20, 2023 | 41.95 | 0.50 | 1.21% | 41.45 | 42.91 | 40.83 |
Mar 17, 2023 | 42.47 | 1.34 | 3.26% | 41.13 | 43.14 | 41.13 |
Mar 16, 2023 | 41.99 | 0.78 | 1.89% | 41.21 | 42.49 | 39.56 |
Mar 15, 2023 | 41.41 | 2.21 | 5.64% | 39.20 | 41.47 | 38.20 |
Mar 14, 2023 | 40.59 | -1.39 | -3.31% | 41.98 | 41.98 | 38.96 |
Mar 13, 2023 | 39.63 | 0.46 | 1.17% | 39.17 | 40.54 | 37.24 |
Mar 10, 2023 | 39.57 | 0.74 | 1.91% | 38.83 | 40.16 | 38.54 |
Mar 9, 2023 | 40.20 | -0.81 | -1.98% | 41.01 | 41.99 | 40.03 |
Mar 8, 2023 | 41.41 | -0.85 | -2.01% | 42.26 | 43.19 | 41.29 |
Mar 7, 2023 | 42.98 | -0.23 | -0.53% | 43.21 | 43.91 | 42.17 |
Mar 6, 2023 | 43.97 | -0.02 | -0.05% | 43.99 | 44.88 | 42.83 |
OrthoPediatrics Corp. Events
Laiks (UTC) (UTC) | Valsts | Notikums |
---|---|---|
No events scheduled |
- Ikgadējs
- Ceturkšņa
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kopējie ienākumi | 122.289 | 98.049 | 71.078 | 72.552 | 57.559 |
Ienākumi | 122.289 | 98.049 | 71.078 | 72.552 | 57.559 |
Cost of Revenue, Total | 31.629 | 24.646 | 16.047 | 17.933 | 14.879 |
Bruto Peļņa | 90.66 | 73.403 | 55.031 | 54.619 | 42.68 |
Kopējie Darbības Izdevumi | 147.688 | 116.073 | 97.833 | 81.629 | 67.112 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 96.933 | 79.275 | 64.529 | 57.211 | 44.987 |
Pētniecība un Attīstība | 8.014 | 5.543 | 5.273 | 5.748 | 4.732 |
Neparedzēti Izdevumi (Ienākumi) | 3.991 | 0.461 | 7.324 | 0.737 | 0 |
Darbības Izdevumi | -25.399 | -18.024 | -26.755 | -9.077 | -9.553 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | 23.506 | -0.447 | -6.932 | -3.538 | -2.255 |
Citi, Neto | -1.796 | 1.083 | 0.02 | -0.07 | -0.217 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -3.689 | -17.388 | -33.667 | -12.685 | -12.025 |
Neto Ienākumi Pēc Nodokļu Nomaksas | 1.258 | -16.26 | -32.944 | -12.685 | -12.025 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | 1.258 | -16.26 | -32.944 | -12.685 | -12.025 |
Ārkārtas Posteņi Kopā | 0 | 0 | -1.046 | ||
Neto Ienākumi | 1.258 | -16.26 | -32.944 | -13.731 | -12.025 |
Total Adjustments to Net Income | 0 | ||||
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 1.258 | -16.26 | -32.944 | -12.685 | -12.025 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 1.258 | -16.26 | -32.944 | -13.731 | -12.025 |
Atšķaidīšanas Iestāstīšana | |||||
Atšķaidītie Neto Ienākumi | 1.258 | -16.26 | -32.944 | -13.731 | -12.025 |
Atšķaidītie Ienākumi par Akcijām | 20.9477 | 19.2683 | 18.0568 | 14.6242 | 12.5674 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 0.06005 | -0.84388 | -1.82446 | -0.8674 | -0.95684 |
Dividends per Share - Common Stock Primary Issue | |||||
Atšķaidītā Normalizētā Peļņa par Akciju | 0.18389 | -0.82832 | -1.56082 | -0.817 | -0.95684 |
Depreciation / Amortization | 7.121 | 6.148 | 4.66 | 2.514 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Kopējie ienākumi | 30.994 | 34.95 | 32.928 | 23.417 | 24.813 |
Ienākumi | 30.994 | 34.95 | 32.928 | 23.417 | 24.813 |
Cost of Revenue, Total | 9.77 | 9.061 | 7.947 | 4.851 | 6.732 |
Bruto Peļņa | 21.224 | 25.889 | 24.981 | 18.566 | 18.081 |
Kopējie Darbības Izdevumi | 39.303 | 41.911 | 36.671 | 29.803 | 30.374 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 27.498 | 27.035 | 26.977 | 22.925 | 21.573 |
Pētniecība un Attīstība | 2.034 | 2.206 | 1.747 | 2.027 | 1.608 |
Neparedzēti Izdevumi (Ienākumi) | 0.001 | 3.609 | 0.461 | ||
Darbības Izdevumi | -8.309 | -6.961 | -3.743 | -6.386 | -5.561 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | 0.541 | 22.302 | 3.798 | -3.136 | 5.114 |
Citi, Neto | -0.128 | -0.945 | -0.827 | 0.105 | 0.281 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -7.896 | 14.396 | -0.772 | -9.417 | -0.166 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -7.848 | 18.539 | -0.333 | -9.1 | 0.072 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -7.848 | 18.539 | -0.333 | -9.1 | 0.072 |
Neto Ienākumi | -7.848 | 18.539 | -0.333 | -9.1 | 0.072 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -7.848 | 18.539 | -0.333 | -9.1 | 0.072 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -7.848 | 18.539 | -0.333 | -9.1 | 0.072 |
Atšķaidītie Neto Ienākumi | -7.848 | 18.539 | -0.333 | -9.1 | 0.072 |
Atšķaidītie Ienākumi par Akcijām | 20.7066 | 21.2953 | 19.7923 | 19.3669 | 19.3046 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -0.37901 | 0.87057 | -0.01682 | -0.46987 | 0.00373 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Atšķaidītā Normalizētā Peļņa par Akciju | -0.37898 | 0.98072 | -0.01682 | -0.46987 | 0.01925 |
- Ikgadējs
- Ceturkšņa
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 133.648 | 158.429 | 128.058 | 97.156 | 69.561 |
Nauda un Īstermiņa Ieguldījumi | 53.543 | 83.899 | 70.777 | 60.691 | 42.582 |
Cash | 7.641 | 28.758 | 70.777 | 60.691 | 42.582 |
Debitoru Parādu Kopsumma, Neto | 17.942 | 17.549 | 16.567 | 9.501 | 5.603 |
Accounts Receivable - Trade, Net | 17.942 | 17.212 | 16.003 | 8.999 | 5.603 |
Total Inventory | 57.569 | 52.989 | 38 | 25.708 | 20.545 |
Prepaid Expenses | 3.229 | 2.618 | 1.464 | 1.256 | 0.831 |
Total Assets | 304.274 | 320.412 | 182.154 | 112.105 | 82.301 |
Property/Plant/Equipment, Total - Net | 28.515 | 27.227 | 21.349 | 12.768 | 10.391 |
Property/Plant/Equipment, Total - Gross | 51.604 | 44.878 | 22.635 | 18.334 | |
Accumulated Depreciation, Total | -23.089 | -17.651 | -9.867 | -7.943 | |
Intangibles, Net | 69.762 | 64.245 | 18.974 | 2.181 | 2.349 |
Total Current Liabilities | 29.715 | 35.028 | 13.663 | 9.217 | 9.467 |
Accounts Payable | 9.325 | 10.038 | 6.467 | 3.971 | 5.495 |
Accrued Expenses | 5.351 | 10.882 | 4.349 | 3.552 | 2.905 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.137 | 0.131 | 0.124 | 0.118 | 0.113 |
Other Current Liabilities, Total | 14.902 | 13.977 | 2.723 | 1.576 | 0.954 |
Total Liabilities | 78.905 | 85.644 | 39.793 | 30.373 | 34.806 |
Total Long Term Debt | 0.907 | 1.044 | 26.067 | 21.156 | 25.339 |
Long Term Debt | 0.907 | 1.044 | 26.067 | 21.156 | 25.339 |
Total Equity | 225.369 | 234.768 | 142.361 | 81.732 | 47.495 |
Redeemable Preferred Stock | 0 | ||||
Common Stock | 0.005 | 0.005 | 0.004 | 0.004 | 0.002 |
Additional Paid-In Capital | 394.899 | 388.622 | 271.182 | 197.442 | 150.424 |
Retained Earnings (Accumulated Deficit) | -178.026 | -161.766 | -128.822 | -115.091 | -103.066 |
Other Equity, Total | 8.491 | 7.907 | -0.003 | -0.623 | 0.135 |
Total Liabilities & Shareholders’ Equity | 304.274 | 320.412 | 182.154 | 112.105 | 82.301 |
Total Common Shares Outstanding | 19.6772 | 19.5603 | 16.7231 | 14.5382 | 12.6218 |
Other Current Assets, Total | 1.365 | 1.374 | 1.25 | ||
Goodwill, Net | 72.349 | 70.511 | 13.773 | ||
Other Liabilities, Total | 43.512 | 43.817 | 0.063 | ||
Treasury Stock - Common | 0 | ||||
Nauda un Ekvivalenti | 45.902 | 55.141 | |||
Deferred Income Tax | 4.771 | 5.755 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 131.424 | 133.648 | 135.459 | 145.388 | 152.028 |
Nauda un Īstermiņa Ieguldījumi | 45.025 | 53.543 | 57.683 | 65.853 | 76.635 |
Cash | 17.957 | 7.641 | 6.334 | 10.565 | 21.426 |
Nauda un Ekvivalenti | 27.068 | 45.902 | 51.349 | 55.288 | 55.209 |
Debitoru Parādu Kopsumma, Neto | 17.911 | 17.942 | 18.205 | 19.317 | 16.874 |
Accounts Receivable - Trade, Net | 17.911 | 17.942 | 18.146 | 19.222 | 16.551 |
Total Inventory | 64.077 | 57.569 | 55.458 | 56.376 | 55.266 |
Prepaid Expenses | 3.048 | 3.229 | 2.745 | 2.471 | 1.884 |
Other Current Assets, Total | 1.363 | 1.365 | 1.368 | 1.371 | 1.369 |
Total Assets | 300.995 | 304.274 | 303.593 | 307.655 | 313.352 |
Property/Plant/Equipment, Total - Net | 31.068 | 28.515 | 28.783 | 28.242 | 28.342 |
Goodwill, Net | 70.987 | 72.349 | 70.49 | 69.656 | 68.463 |
Intangibles, Net | 67.516 | 69.762 | 68.861 | 64.369 | 64.519 |
Total Current Liabilities | 34.333 | 29.715 | 28.018 | 30.329 | 36.623 |
Accounts Payable | 14.578 | 9.325 | 8.972 | 10.142 | 12.009 |
Accrued Expenses | 4.433 | 5.351 | 4.655 | 5.651 | 10.1 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.139 | 0.137 | 0.136 | 0.134 | 0.132 |
Other Current Liabilities, Total | 15.183 | 14.902 | 14.255 | 14.402 | 14.382 |
Total Liabilities | 85.951 | 78.905 | 82.475 | 86.054 | 91.207 |
Total Long Term Debt | 0.872 | 0.907 | 0.942 | 0.977 | 1.011 |
Long Term Debt | 0.872 | 0.907 | 0.942 | 0.977 | 1.011 |
Deferred Income Tax | 4.335 | 4.771 | 4.848 | 5.06 | 5.233 |
Other Liabilities, Total | 46.411 | 43.512 | 48.667 | 49.688 | 48.34 |
Total Equity | 215.044 | 225.369 | 221.118 | 221.601 | 222.145 |
Common Stock | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
Additional Paid-In Capital | 396.425 | 394.899 | 392.929 | 391.415 | 390 |
Retained Earnings (Accumulated Deficit) | -187.126 | -178.026 | -178.098 | -175.901 | -172.145 |
Other Equity, Total | 5.74 | 8.491 | 6.282 | 6.082 | 4.285 |
Total Liabilities & Shareholders’ Equity | 300.995 | 304.274 | 303.593 | 307.655 | 313.352 |
Total Common Shares Outstanding | 19.8213 | 19.6772 | 19.6722 | 19.67 | 19.6594 |
- Ikgadējs
- Ceturkšņa
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Neto ienākumi/Sākuma Līnija | -16.26 | -32.944 | -13.731 | -12.025 | -8.932 |
Nauda no Darbības | -13.063 | -18.53 | -17.769 | -15.583 | -7.217 |
Nauda no Darbības | 10.68 | 8.01 | 4.671 | 2.892 | 2.405 |
Bezskaidras Naudas Preces | 6.196 | 12.113 | 2.669 | 3.185 | 3.478 |
Samaksātie Procenti Naudā | 0.056 | 1.233 | 4.229 | 2.255 | 2.49 |
Izmaiņas Apgrozāmajā Kapitālā | -12.551 | -4.986 | -11.378 | -9.635 | -4.168 |
Nauda no Ieguldījumu Darbībām | -7.411 | -69.693 | -61.922 | -5.965 | -6.544 |
Kapitālie Izdevumi | -16.011 | -11.3 | -12.086 | -5.463 | -6.544 |
Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | 8.6 | -58.393 | -49.836 | -0.502 | 0 |
Nauda no Darbībām ar Finansēšanu | 0.006 | 46.732 | 91.019 | 39.657 | 54.734 |
Naudas Plūsma Finansēšanas Posteņos | 0 | 0 | -0.99 | ||
Akciju Izsniegšana (Atkāpšanās), Neto | 0.137 | 71.857 | 61.137 | 43.835 | 53.775 |
Parādu Izsniegšana (Atkāpšanās), Neto | -0.131 | -25.125 | 29.882 | -4.178 | 7.914 |
Ārvalstu Valūtas Ietekme | -0.658 | -0.404 | 0.008 | ||
Neto Izmaiņas Naudā | -21.126 | -41.895 | 11.336 | 18.109 | 40.973 |
Total Cash Dividends Paid | 0 | 0 | -5.965 | ||
Deferred Taxes | -1.128 | -0.723 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -9.1 | -16.26 | -16.332 | -14.135 | -10.379 |
Cash From Operating Activities | -4.197 | -13.063 | -11.828 | -10.891 | -1.915 |
Cash From Operating Activities | 2.961 | 10.68 | 7.87 | 5.147 | 2.539 |
Deferred Taxes | -0.317 | -1.128 | -0.89 | -0.602 | -0.312 |
Non-Cash Items | 4.549 | 6.196 | 9.581 | 9.083 | 6.11 |
Cash Interest Paid | 0.013 | 0.056 | 0.043 | 0.029 | 0.015 |
Changes in Working Capital | -2.29 | -12.551 | -12.057 | -10.384 | 0.127 |
Cash From Investing Activities | 14.303 | -7.411 | -10.376 | -7.332 | -5.607 |
Capital Expenditures | -4.197 | -16.011 | -14.376 | -7.332 | -5.607 |
Other Investing Cash Flow Items, Total | 18.5 | 8.6 | 4 | 0 | 0 |
Cash From Financing Activities | -0.033 | 0.006 | 0.04 | -0.002 | 0.03 |
Issuance (Retirement) of Stock, Net | 0 | 0.137 | 0.137 | 0.062 | 0.062 |
Issuance (Retirement) of Debt, Net | -0.033 | -0.131 | -0.097 | -0.064 | -0.032 |
Foreign Exchange Effects | 0.241 | -0.658 | -0.266 | 0.029 | 0.155 |
Net Change in Cash | 10.314 | -21.126 | -22.43 | -18.196 | -7.337 |
Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
---|---|---|---|---|---|---|
Squadron Capital LLC | Corporation | 30.0162 | 6901764 | 1525000 | 2022-09-20 | LOW |
Brown Capital Management, LLC | Investment Advisor | 13.8126 | 3175993 | -205041 | 2022-12-31 | LOW |
Brown Advisory | Investment Advisor/Hedge Fund | 6.897 | 1585854 | 18238 | 2022-12-31 | LOW |
Riverbridge Partners, LLC | Investment Advisor | 4.611 | 1060238 | -53264 | 2022-12-31 | LOW |
Braidwell LP | Hedge Fund | 4.5435 | 1044699 | 1044699 | 2022-12-31 | |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.101 | 942959 | 83752 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.4557 | 794591 | 8351 | 2022-12-31 | LOW |
Next Century Growth Investors, LLC | Investment Advisor | 2.4321 | 559222 | 12762 | 2022-12-31 | MED |
Granahan Investment Management, Inc. | Investment Advisor | 2.2069 | 507432 | 128239 | 2022-12-31 | LOW |
New York State Common Retirement Fund | Pension Fund | 2.0359 | 468116 | 29205 | 2022-12-31 | LOW |
AWM Investment Company, Inc. | Investment Advisor/Hedge Fund | 1.7207 | 395658 | 50183 | 2022-12-31 | LOW |
Wasatch Global Investors Inc | Investment Advisor/Hedge Fund | 1.6793 | 386135 | 243 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.6321 | 375273 | 15426 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.5458 | 355441 | 28035 | 2022-12-31 | LOW |
D. F. Dent & Company, Inc. | Investment Advisor | 1.3965 | 321103 | -79936 | 2022-12-31 | LOW |
First Light Asset Management, LLC | Investment Advisor/Hedge Fund | 1.3166 | 302731 | -5997 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.311 | 301436 | 36821 | 2022-12-31 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 1.1857 | 272628 | -621 | 2022-12-31 | LOW |
Allspring Global Investments, LLC | Investment Advisor/Hedge Fund | 1.1309 | 260029 | -80814 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 1.0858 | 249658 | 249658 | 2022-12-31 | HIGH |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group500K+
Tirgotāji
92K+
Ikmēneša aktīvie klienti
$53M+
Ikmēneša ieguldījumu apjoms
$30M+
Izņemts katru mēnesi
Treidinga kalkulators
Aprēķiniet iespējamo peļņu un zaudējumus, uzsākot CFD darījumu noteiktā dienā (izvēlaties datumu) un slēdzot darījumu citā dienā (izvēlaties datumu).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
OrthoPediatrics Corp. Company profile
Par OrthoPediatrics Corp.
OrthoPediatrics Corp. ir medicīnas ierīču uzņēmums, kas projektē, izstrādā un tirgo anatomiski piemērotus implantus un ierīces bērniem ar ortopēdiskām saslimšanām, sniedzot bērnu ortopēdijas ķirurgiem un aprūpētājiem. Uzņēmums darbojas OrthoPediatrics segmentā, kas projektē, izstrādā un tirgo anatomiski piemērotus implantus un ierīces bērniem ar ortopēdiskām problēmām. Uzņēmums dažādām slimnīcām un medicīnas iestādēm Amerikas Savienotajās Valstīs un dažādos starptautiskos tirgos piedāvā virkni produktu, tostarp PediLoc, PediPlates, kaniulētās skrūves, PediFlex nail, PediNail, PediNail, PediLoc Tibia, ACL rekonstrukcijas sistēmu, bloķēšanas kaniulēto asmeni, bloķēšanas proksimālo augšstilba kaulu, Spica tabulas, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform Femur, Orthex, QuickPack un ApiFix Mid-C sistēmu.
Industry: | Medical Devices & Implants |
2850 Frontier Drive
46582
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 500 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com